#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prophylaxis against transplant rejection Mucopolysaccharidosis III Central nervous system lymphoma Cutaneous T-cell lymphoma Erythema multiforme Colorectal cancer metastatic Congenital leptin deficiency Cognitive disorder Hormone-dependent prostate cancer Primary immunodeficiency syndrome Henoch-Schonlein purpura nephritis Short stature homeobox gene mutation Philadelphia positive acute lymphocytic leukaemia Craniopharyngioma Dent's disease More trials…

    Learn about Rare Diseases

    Phenylketonuria – Treatment Hairy cell leukaemia recurrent – Basic Information Uterine leiomyosarcoma – Treatment Haemophilia B with anti factor IX – Basic Information Behcet’s syndrome – Basic Information Osteosarcoma metastatic – Diagnostics Prader-Willi syndrome – Diagnostics Toxic epidermal necrolysis Rhabdomyosarcoma – Trials in Disease Factor IX deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Phleum Pratense (225) OSIMERTINIB MESYLATE Arbaclofen TRIMIPRAMINE MALEATE Cefalexin Islatravir Mecasermin Rinfabate Atezolizumab Escitalopram Miglustat Clascoterone Tamoxifen Crizanlizumab Sulfasalazine Dog Epithelia Cagrilintide Ferric Carboxymaltose Amisulpride Alternaria Alternata Extract Bidridistrogene Xeboparvovec More therapies…

    Learn about Your Condition

    Thyroid mass Ligament sprain Urticaria Neuropathic arthropathy Bronchitis Colorectal cancer metastatic Dry mouth Small cell lung cancer Myxofibrosarcoma Dedifferentiated liposarcoma Schizoaffective disorder Immune-mediated enterocolitis Friedreich's ataxia Von Hippel-Lindau disease Supraventricular tachycardia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Primary mediastinal large B-cell lymphoma

  • Study on Acalabrutinib with Rituximab and Drug Combination for Older Adults with Untreated Diffuse Large B-Cell Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Prednisolone
    • Acalabrutinib
    • Cyclophosphamide
    Germany Greece

  • Study of CD19-CAR_Lenti, Fludarabine, and Cyclophosphamide in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia or Aggressive B-Cell Lymphomas

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Primary mediastinal large B-cell lymphoma
    • Acute lymphocytic leukaemia
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
    • Cyclophosphamide
    • Fludarabine Phosphate
    Italy

  • Study of Axicabtagene Ciloleucel for Patients with Relapsed or Refractory Primary Mediastinal B-Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Primary mediastinal large B-cell lymphoma
    Investigated Drugs:
    • Axicabtagene Ciloleucel
    Germany

  • Study of Rapcabtagene Autoleucel and Ibrutinib for Adults with Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Other Blood Cancers

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Primary mediastinal large B-cell lymphoma
    • High-grade B-cell lymphoma
    • Follicular lymphoma
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Cyclophosphamide Monohydrate
    • Cytarabine
    Austria France Germany Italy Spain

  • Study of Pembrolizumab with Hyaluronidase for Patients with Relapsed or Refractory Hodgkin Lymphoma or Primary Mediastinal Large B-cell Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Primary mediastinal large B-cell lymphoma
    • Hodgkin’s disease
    Investigated Drugs:
    • Pembrolizumab
    Germany Poland Spain

  • Study of Tisagenlecleucel for Adults with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Primary mediastinal large B-cell lymphoma
    • High-grade B-cell lymphoma
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Tisagenlecleucel
    • Dexamethasone Acetate
    • Bendamustine Hydrochloride
    Austria France Germany Italy The Netherlands Norway +1
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!